Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Bosutinib – Chronic Myelogenous Leukaemia (CML) Treatment

Bosutinib is an investigational drug indicated for treating Philadelphia chromosome positive Chronic Myelogenous Leukaemia.

Go Top